Evolus, Inc. ( EOLS) - Stock Earnings
EOLS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
EOLS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 130000 USD | 90.3 million USD |
| 2026Q1 | -10.7 million USD | 73.1 million USD |
| 2026Q2 | -8.1 million USD | 84.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EOLS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.7 million USD | 202.1 million USD |
| 2024 | -50.4 million USD | 266.3 million USD |
| 2025 | -51.6 million USD | 297.2 million USD |
| 2026 Est. | — | — |
EOLS
Price: $7.15
Earnings Per Share: -0.53 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 16622
Market Capitalization: 470.2 million